You'll receive the latest updates on new standards, guidelines, and educational resources, as well as expert insights to help enhance your laboratory's performance and compliance.
July 8, 2025
Attending ADLM 2025? Don't miss these key talks!
ADLM 2025 | Bring the Wonder is coming up 27-31 July in Chicago, Illinois. Make sure not to miss these CLSI experts presenting!
View the full conference agenda here.
ADLM 2025 | Bring the Wonder is coming up 27-31 July in Chicago, Illinois. Make sure not to miss these CLSI experts presenting!
View the full conference agenda here.
- Pamela Banning, BS, MLS (ASCP) - "The benefits of LOINC to the IVD industry: Captured in a LIVD file"
- Rebekah Dumm, PhD - "Emerging pathogens: Science, strategy, and lab readiness"
- Kornelia Galior, PhD, DABCC - "Implementing a new test or a new instrument? A crash course on method evaluation" and "Is my patient’s result real? Considerations when interpreting endocrine laboratory tests"
- Daniel Holmes, MD, FRCPC - "Approaches and assumptions in laboratory reference interval determination"
- Patrick Kyle, PhD, ABFT, DABCC - "CSI clinical lab: Addressing the legal implications of your clinical lab results"
- Sonia La'ulu, BS, MBA, C(ASCP) - "Stick to the norm: Performing reference interval verification studies"
- Sara Love, PhD, DABCC - "Put me in coach: Professional development as an extension of your quality improvement mindset"
- Alicia Lyle, PhD - "Improving the quality of biomarkers for cardiovascular diseases: The next stage of the CDC Cardiovascular Disease Biomarker Standardization Programs"
- Peggy Mann, MS, MT (ASCP), CPP - "Skills to solve problems and resolve challenges in point-of-care testing"
- James Nichols, PhD, DABCC, FADLM - "Improving laboratory analysis and continuous glucose monitoring (CGM) quality to optimize diabetes therapy"
- Marc Rumpler, PhD, MBA, DLM, C (ASCP), DABCC, FADLM, NRCC - "Leadership and management strategies for optimizing laboratory workflows and fostering collaborative team dynamics in diagnostic settings"
- Aleksei Tikhonov, MSc, PhD - "The role of measuring cytokines in cancer immunotherapy"
- Melanie Yarbrogh, PhD, DABCC, ABMM -"Let’s talk about STIs, baby: Considerations for STI diagnoses and pharmacologic changes during pregnancy" and "When urine trouble and it ‘snot straightforward: Clinically relevant thresholds for workup of urine and respiratory cultures"
- Brian Rappold, BS - Updated guidance and best practices in clinical implementation of LC-MS/MS
- Alison Woodworth, PhD, DABCC, FADLM - Learning from the errors of others: An exploration of error in the total analytical process
- Jeanne Mumford, BS, MLS(ASCP) - Skills to solve problems and resolve challenges in point-of-care testing
- Kathleen David, BA, ASCP, MT (ASCP) - Thinking outside the box: Bringing laboratory testing to the patient
- Ruhan Wei, PhD, DABCC, NRCC - Assay interference: Tracking analytical difficulties in a clinical central automated laboratory setting
- Greg Miller, PhD, DABCC - Laboratory test harmonization and standardization: The need, the roadmap, and a model example and What the lab reports matters: Impact of eGFR reporting on drug decisions in clinical practice
- J Shirley Li, MD, PhD, DABCC, NRCC, FCACB - Advancing patient safety through global laboratory quality indicators: Insights from the IFCC model
- Octavia Peck Palmer, PhD - Supporting healthy Indigenous communities through laboratory medicine and public health
- John Toffaletti, PhD, DABCC - The harmonious path forward for serum creatinine, cystatin C, and eGFRs
- Qing Meng, PhD, MD, DABCC, FADLM - The role of measuring cytokines in cancer immunotherapy and Global working groups advancing diagnostics and laboratory medicine: Achievements, gaps, and future directions
- Rongrong Huang, PhD, DABCC - Practical considerations in evaluating screening and confirmation urine drug tests: Fentanyl as an example
